Private biotechs Caldera and Vidya raise $478M collectively in reverse go-public mergers
Private biotechs Caldera and Vidya raise $478M collectively in reverse go-public mergers. Reported by BioSpace on 2026-07-29.
Caldera Therapeutics
Private
Caldera Therapeutics is a privately held biopharmaceutical company developing targeted therapies for immunology and inflammation. In 2026, the company announced plans to go public via a reverse merger transaction raising approximately $478M collectively with Vidya Therapeutics.
Company Info
Sector:Biotechnology
Headquarters:South San Francisco, California, USA
Founded:2019
Website:www.calderatx.com/
Upcoming Milestones & Key Dates
2026
Corporate
Closing of reverse merger to go public
2027
Regulatory
Anticipated IND filing for lead immunology candidate
Clinical Development Pipeline
Undisclosed
Target: TBDUndisclosed
Target: TBDUndisclosed
Target: TBDRecent News
Leadership Team
To be confirmed
Chief Executive Officer
To be confirmed
Chief Scientific Officer
To be confirmed
Chief Medical Officer